Biofire Diagnostics, LLC
Explore this company’s associated devices, FDA decisions and regulatory history.

Biofire Diagnostics, LLC
- Regulatory records
- 2
- Linked recall entries
- 3
- Headquarters
- Not reported
- Brand website
- biofiredx.com
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name Biofire Diagnostics, LLC. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Oct 21, 2026 to Nov 6, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code PCH appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 515 Colorow Dr., Salt Lake City, UT, 84108, US. Recorded on K262172, decision dated Nov 6, 2026.
Device categories in this collection
Gastrointestinal Pathogen Panel Multiplex Nucleic Acid-Based Assay System; Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Recalls linked to this firm
MedtechLedger links 3 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 3 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Biofire Diagnostics, LLC | Class II | Oct 21, 2026 | FDA | |
| Biofire Diagnostics, LLC | Class II | Oct 21, 2026 | FDA | |
| Biofire Diagnostics, LLC | Class II | Oct 21, 2026 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 19, 2026.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biofire Diagnostics, LLC | 510(k) clearance | Nov 6, 2026 | FDA | |
| Biofire Diagnostics, LLC | 510(k) clearance | Oct 21, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 19, 2026.


